
In 2021, the global Infectious Disease Molecular Diagnostics Market was estimated to be worth approximately US$ 34 billion. With a projected CAGR of 4.2% over the next ten years, the market is expected to be worth nearly US$ 53 billion by the end of 2032.
FMI, in its business report, elaborates the historical and current scenario of the global Infectious Diseases Molecular Diagnostics Market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.
Crucial information and forecast statistics covered in the Infectious Diseases Molecular Diagnostics market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.
COVID-19 Impact Analysis on Infectious Diseases Molecular Diagnostics Market
The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Infectious Diseases Molecular Diagnostics market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Infectious Diseases Molecular Diagnostics market.
Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.
The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Infectious Diseases Molecular Diagnostics market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.
Browse More@ https://www.futuremarketinsights.com/reports/infectious-diseases-molecular-diagnostics-market
Infectious Diseases Molecular Diagnostics Market: Segmentation
Valuable information covered in the FMI’s Infectious Diseases Molecular Diagnostics market report has been segregated into key segments and sub-segments.
By Technology:
- Polymerase chain reaction (PCR)
- In Situ Hybridization
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Chips and Microarrays
- Mass Spectrometry
- Sequencing
- Others
By Product Type:
- Instruments
- Reagents
- Services
By End Use:
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
By Application:
- Respiratory Diseases
- Tuberculosis
- Meningitis
- Gastrointestinal Tract Infections
- HPV
- Sexually Transmitted Infections
- Sepsis
- Drug Resistance Diseases
- Other Infectious Diseases
Key players covered in the report include:
F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Abbott Laboratories, bioMérieux SA, QIAGEN N.V., Myriad Genetics, Inc., Siemens Healthineers AG, Danaher Corporation, Illumina, Inc., Others